FIELD: pharmaceutical industry. SUBSTANCE: present invention describes compounds of general formula I: $$$ in the form of 22R and 22S-epimers wherein $$$ and $$$ are same of different and each is hydrogen atom or fluorine atom provided that $$$ and $$$ are not simultaneously hydrogen atoms. The present invention also describes methods of preparation of said compounds, pharmaceutical agents which comprise said compounds and use of said compounds for treating inflammatory and allergic diseases. EFFECT: improved properties of the pharmaceutical composition. 10 cl
Title | Year | Author | Number |
---|---|---|---|
STEROID ESTERS OR THEIR STEREOISOMERS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2112775C1 |
16α,17a-ACETAL-SUBSTITUTED ANDROSTANE-17b-CARBOXYLIC ACID ESTERS OR THEIR STEREOISOMERS | 1991 |
|
RU2081879C1 |
COMPOSITION FOR PER OS TREATING INFLAMMATORY GASTROENTERIC TRACT DISEASES | 1990 |
|
RU2134104C1 |
METHOD SYNTHESIS OF (22R,S)-α-BUTYLIDENEDIHYDROXY-a-DIHYDROXYPREGNA-1,4-DIENE- -3,20-DIONE | 1990 |
|
RU2048472C1 |
METHOD FOR CONDITIONING SUBSTANCES | 1994 |
|
RU2148992C1 |
APPLICATION OF H, K-ATPase INHIBITOR FOR TREATING NASAL POLYPS | 1997 |
|
RU2197966C2 |
0 |
|
SU1779257A3 | |
DIDEOXYDIDEHYDROCARBOCYCLIC NUCLEOSIDES, PHARMACEUTICAL COMPOSITION | 1989 |
|
RU2114846C1 |
METHOD FOR PREPARING FLUMETASONE, COMPOUND | 2002 |
|
RU2260596C1 |
DERIVATIVES OF ANDROSTENE, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2194053C2 |
Authors
Dates
1998-05-20—Published
1992-01-29—Filed